EORTC Trial 10801

👉The EORTC Trial 10801 was a randomized multicenter trial that compared breast-conserving therapy with MRM for patients with invasive breast cancer less than 5 cm in diameter.

👉At 10 years, there was no difference between the two groups in OS or in distant metastasis-free rates.

👉Locoregional recurrence at 10 years was 12% for the mastectomy group and 20% for the breast-conserving therapy group.

#Arrangoiz #BreastCancer #BreastSurgeon #CancerSurgeon #SurgicalOncologist

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s